Site Search

Share

X

Search Results

Victory for Public Health: ACS CAN Applauds Decision to Reject Flawed Biomarker Legislation

... CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) applauds the Senate for not supporting House Bill 4753, the biomarker testing legislation, which was supposed to allow West Virginians to get the testing they need and not fall farther behind other states. West Virginia patients deserve access to proven and necessary biomarker tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better ...

2024 West Virginia Cancer Action Day Webpage

... . Pre-Event Material Recording and Slides Below : Pre-event Training Recording  24_wv_volunteer_training_presentation_.pdf  Biomarker Fact Sheets Mentioned in the Pre-Training: biomarker_testing_costs_and_cost_savings.pdf acs_can_biomarker_testing_patient_profiles_final_0.pdf ...

Delegate Westfall files legislation aimed at improving health outcomes in West Virginia

CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by health insurance and ...

House Passes Legislation That Won’t Improve Health Outcomes

CHARLESTON, W. VA . – Today, the West Virginia House passed House Bill 4753, which was supposed to ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance ... Network (ACS CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) urges the Senate to amend House Bill 4753, the biomarker testing legislation, to allow West Virginians to get the testing they need and not fall farther behind other states. West Virginia ...

2024 West Virginia Legislative Priorities

... for all insurance plans, including traditional Medicaid, to provide a comprehensive benefit for lung cancer screening including all follow-up testing according to recommended guidelines, without enrollee cost sharing or other barriers. Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy